▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3950 by analyst upside · 2026-06-27
TECH
Bio-Techne Corporation
Healthcare · Market Cap $11B · P/E 101.4x
ANALYST PRICE TARGET
-7.4%
implied upside to consensus target
Current Price $71.0
Consensus Target $65.75
Bull Target $75.0
Bear Target $50.0
Analysts Covering 12
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
8
Hold
3
Sell
0
52-Week Low $43.2
52-Week High $72.16
YTD Return +19.4%
FUNDAMENTALS
Market Cap $11B
P/E Ratio (TTM) 101.4x
Forward P/E 34.7x
EPS (TTM) $0.70
PEG Ratio 0.81
Dividend Yield 0.45%
Revenue (TTM) $1.2B
Profit Margin 9.0%
52-WEEK RANGE
52-Week Low $43.2
52-Week High $72.16
Current Price $71.0
Bear Target $50.0
Bull Target $75.0
● Now $71.0 ● Target $65.75
TRADING DATA
Avg Volume 3.5M
YTD Return +19.4%
Analyst Count 12
Consensus Buy
Upside to Target -7.4%
Last Updated 2026-06-27

ANALYST SUMMARY

Bio-Techne Corporation (TECH) is currently trading at $71.0 with a Wall Street consensus price target of $65.75, which is 7.4% below the current price over the next 12 months. 12 analysts currently cover TECH, with a consensus rating of Buy — 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $75.0, while the most cautious has a target of $50.0.

TECH operates in the Healthcare sector with a market capitalisation of $11B. The stock is up 19.4% year-to-date and is currently trading near the upper end of its 52-week range of $43.2 – $72.16.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

ICLR +3.2%
ICON Public Limited Company
$13B · P/E 74.8x · Buy
MOH -16.5%
Molina Healthcare, Inc.
$12B · P/E 61.4x · Hold
PEN +15.1%
Penumbra, Inc.
$12B · P/E 72.8x · Hold
ALKS -12.6%
Alkermes plc
$9B · P/E 61.2x · Buy
RVTY +0.6%
Revvity, Inc.
$13B · P/E 54.6x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for TECH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Piper Sandler ● Initiated
Neutral 2026-06-11 14% win rate (7 calls)
Citigroup — Reiterated
Buy → Buy 2026-05-07 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-05-07 Building track record
Evercore ISI Group — Reiterated
In-Line → In-Line 2026-05-07 Building track record
Evercore ISI Group — Reiterated
In-Line → In-Line 2026-04-06 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-02-06 Building track record
Citigroup — Reiterated
Buy → Buy 2026-02-05 Building track record
Stifel — Reiterated
Hold → Hold 2026-02-05 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →